Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950109-96-001807
Filing Date
1996-03-28
Accepted
1996-03-28 00:00:00
Documents
13
Period of Report
1995-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 207542
2 2ND AMENDMENT TO OPTION AGREEMENT 11/15/95 EX-10.16.3 7518
3 ARRANGEMENT WITH SOMERSET CENTRAL EX-10.26 880
4 1995 STOCK OPTION PLAN EX-10.30 29468
5 RESEARCH & DEVELOPMENT AND OPTION AGREEMENT 12/14/95 EX-10.31 61975
6 DISTRIBUTION AGREEMENT 12/22/95 EX-10.32 51339
7 DISTRIBUTION AGREEMENT 01/16/96 EX-10.33 52572
8 SEVERANCE AGREEMENT THOMAS J. MCKEARN EX-10.34 9562
9 SEVERANCE AGREEMENT RICHARD J. WALSH EX-10.35 534
10 HOROSZIEWICZ - CYTOGEN AGREEMENT 04/20/89 EX-10.36 31679
11 SUBSIDIARIES OF CYTOGEN CORPORATION EX-21 463
12 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS 03/25/96 EX-23 1324
13 FINANCIAL DATA SCHEDULE EX-27 2365
  Complete submission text file 0000950109-96-001807.txt   460075
Mailing Address 600 COLLEGE RD EAST CN 5308 600 COLLEGE RD EAST CN 5308 PRINCETON NJ 08540
Business Address 600 COLLEGE RD EAST CN 5308 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Filer) CIK: 0000725058 (see all company filings)

EIN.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14879 | Film No.: 96539691
SIC: 2835 In Vitro & In Vivo Diagnostic Substances